dr. Andreas Herrmann

New biological entities, biosimilars, biobetters and the latest technologies applied for efficient bioprocessing in Upstream and Downstream of these entities

More about this topic will follow.

About dr. Andreas Herrmann

Dr. Andreas Herrmann, Founder of Probiocon, has more than 20 year experience within the development of biopharmaceutical compounds in different biotechnological companies. In 1994, he received his PhD in biochemistry in the field of neurobiology and afterwards he worked as an associate professor in the department of cardiovascular physiology at the University of Cologne. In 1996 he was cofounder of Cardion AG heading the research and development up to 2003.  Since 2003 Dr. Herrmann has founded and headed several biotechnological companies, which are either contract manufacturing organizations such as the Celonic AG in Basel, Celonic GmbH in Jülich or companies developing biopharmaceutical compounds up to clinical phase II (Baliopharm AG, Synimmune Gmbh, Xiopharm AG). During his career, he served as a consultant for many pharma and venture companies e.g. Roche, Glycothera, JRS, TVM, Centus Capital, and others.

www.probiocon.com

me